Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.

Int J Womens Health · 2013 · PMC3792833 · PMID 24109197

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

15 The study showed a highly significant increase in vaginal epithelial cells and a significant decrease in parabasal cells in both ospemifene groups compared with placebo.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.